Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 29:7:F1000 Faculty Rev-1354.
doi: 10.12688/f1000research.14789.1. eCollection 2018.

Recent advances in understanding corticotroph pituitary tumor initiation and progression

Affiliations
Review

Recent advances in understanding corticotroph pituitary tumor initiation and progression

Ulrich Renner et al. F1000Res. .

Abstract

Cushing's disease is the most frequent form of hypercortisolism and is caused by hypophyseal corticotroph adenomas secreting excessive amounts of adrenocorticotropic hormone. Most of the tumors develop sporadically and only a limited number of corticotroph adenomas have been found to be associated with different neuroendocrine syndromes or with familial isolated pituitary adenomas. The pathogenic mechanisms of corticotroph adenomas are largely unknown, but the discovered aberrant chaperoning activity of heat shock protein 90 on the one hand and the presence of ubiquitin-specific protease 8 mutations on the other hand partially explained the causes of their development. Corticotroph tumors arise initially as benign microadenomas but with time form invasively growing aggressive macroadenomas which can switch to corticotroph carcinomas in extremely rare cases. The mechanisms through which corticotroph tumors escape from glucocorticoid negative feedback are still poorly understood, as are the processes that trigger the progression of benign corticotroph adenomas toward aggressive and malignant phenotypes. This review summarizes recent findings regarding initiation and progression of corticotroph pituitary tumors.

Keywords: USP8 mutation; corticotroph carcinoma; corticotroph tumor; progression.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

References

    1. Pivonello R, De Leo M, Cozzolino A, et al. : The Treatment of Cushing's Disease. Endocr Rev. 2015;36(4):385–486. 10.1210/er.2013-1048 - DOI - PMC - PubMed
    1. Mete O, Lopes MB: Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr Pathol. 2017;28(3):228–43. 10.1007/s12022-017-9498-z - DOI - PubMed
    1. Lodish M: Cushing's syndrome in childhood: update on genetics, treatment, and outcomes. Curr Opin Endocrinol Diabetes Obes. 2015;22(1):48–54. 10.1097/MED.0000000000000127 - DOI - PMC - PubMed
    1. Xiong Q, Ge W: Gene mutations in Cushing's disease. Biomed Rep. 2016;5(3):277–82. 10.3892/br.2016.729 - DOI - PMC - PubMed
    1. Ben-Shlomo A, Cooper O: Silent corticotroph adenomas. Pituitary. 2018;21(2):183–93. 10.1007/s11102-018-0864-8 - DOI - PubMed

Publication types

MeSH terms